Departments & Organizations
I have dedicated my career to the development of diagnostic and therapeutic tools with the potential to positively affect the health of people worldwide, particularly those living in poverty. Until 2013, I was an assistant professor at the Center for Biomedical Research Excellence (COBRE) at the University of Vermont, where I developed translational research programs for dengue fever, typhoid fever, and other infectious diseases in collaboration with clinical trials directed by Dr. Beth Kirkpatrick. To focus more directly on diseases that disproportionately affect people in developing countries, I joined Albert Ko's group as junior faculty at Yale University to build a translational research program for leptospirosis at the Oswaldo Cruz Foundation in Brazil. Leptospirosis is a rapidlly emerging zoonotic disease of urban poverty, with a wide spectrum of clinical manifestations, including massive pulmonary hemorrhage and Weil's disease. My current work aims to answer important questions about the of immunology of Leptospira infections, such as whether long term immunity to Leptospira occurs after infection, and whether specific immune responses are associated with poor disease outcomes. Simultaneously with projects to create state-of-the-art approaches in immunology at Fiocruz, I'm working to create the infrastructure to implement vaccines in Fiocruz field locations and building research capacity in Brazil.
Education & Training
|PhD||Massachusetts Institute of Technology (2002)|
|BS||University of Illinois - Urbana, Microbiology (1996)|
|Post-Doctoral Associate||University of Vermont|
|Post-Doctoral Fellow||University of Colorado - Boulder|